| Market Cap | ₹8.20Cr |
| ROE | -6.62% |
| P/E Ratio(TTM) | -25.63 |
| EPS(TTM) | -0.08 |
| P/B Ratio | 1.78 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.18 |
| Book Value | 1.15 |
| Debt to Equity | 2.20 |
| Face Value | 1 |
| Parent Organisation | Vivanza Biosciences Limited |
| Managing Director | Mr. Jayendra Mehta |
| BSE Symbol | 530057 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.94 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 |